| Quarterly Financials | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 270 | 285 | 278 | 275 | 276 | 691 | 835 | 831 | 1,026 | 1,050 | 1,023 | 964 | 1,098 | 1,163 | 1,186 | 1,255 | 1,326 | 1,409 | 1,381 | 1,468 | 1,578 | 1,748 | 1,902 | 1,957 | 2,064 |
| Expenses | 239 | 253 | 245 | 228 | 514 | 564 | 636 | 634 | 756 | 787 | 729 | 729 | 802 | 818 | 828 | 874 | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,443 | 1,398 | 1,505 |
| EBITDA | 31 | 31 | 32 | 47 | -239 | 127 | 200 | 197 | 270 | 262 | 293 | 235 | 296 | 345 | 359 | 381 | 379 | 433 | 432 | 427 | 422 | 491 | 459 | 559 | 559 |
| Operating Profit % | 9 % | 10 % | 8 % | 8 % | -101 % | 13 % | 20 % | 21 % | 24 % | 23 % | 25 % | 22 % | 25 % | 28 % | 28 % | 28 % | 26 % | 28 % | 29 % | 27 % | 25 % | 26 % | 23 % | 27 % | 26 % |
| Depreciation | 12 | 11 | 11 | 12 | 26 | 52 | 48 | 48 | 54 | 54 | 55 | 58 | 57 | 58 | 57 | 60 | 56 | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 |
| Interest | 10 | 21 | 27 | 25 | 35 | 53 | 46 | 45 | 27 | 27 | 25 | 22 | 22 | 22 | 20 | 20 | 19 | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 |
| Profit Before Tax | 9 | -0 | -6 | 10 | -300 | 22 | 105 | 105 | 190 | 182 | 213 | 154 | 216 | 265 | 281 | 301 | 304 | 366 | 360 | 336 | 321 | 374 | 309 | 403 | 400 |
| Tax | -0 | 1 | -4 | -43 | 14 | 6 | 15 | 35 | 43 | 37 | 23 | 31 | 44 | -192 | 59 | 50 | 63 | 90 | 70 | 84 | 85 | 92 | 70 | 84 | 93 |
| Net Profit | 9 | -1 | -2 | 53 | -314 | 17 | 90 | 70 | 147 | 145 | 190 | 124 | 173 | 457 | 222 | 251 | 240 | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 |
| EPS in ₹ | 0.17 | -0.03 | -0.03 | 0.91 | -4.34 | 0.18 | 1.00 | 0.76 | 1.52 | 1.50 | 1.96 | 1.28 | 1.78 | 4.72 | 2.29 | 2.58 | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 |
Max Healthcare Institute
Max Healthcare Institute
1,255.00
+4.90
(0.39%)
Company has added their latest Transcript11 hours ago
View
Market Cap
1,22,004.43 Cr
EPS
11.07
PE Ratio
101.30
Dividend Yield
0.12 %
Industry
Healthcare Services52 Week High
1,314.30
52 Week Low
836.60
PB Ratio
12.95
Debt to Equity
0.24
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from20 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,255.00 | #1 1,22,004.43 | #9 101.30 | #3 7,184.10 | #1 28.68 | #2 1,076 | #5 30.34 | 51.14 | |
7,895.00 | 1,13,517.99 | 72.42 | #1 21,994.30 | 14.76 | #1 1,505 | 39.78 | 70.51 | |
944.55 | 71,309.57 | 77.40 | 7,849.70 | 13.25 | 809 | #1 53.33 | 72.05 | |
1,847.90 | 37,763.83 | 47.72 | 5,575.00 | 12.29 | 790 | -2.38 | 46.73 | |
1,398.40 | 37,559.26 | 65.47 | 3,692.32 | 21.40 | 486 | 49.58 | 60.25 | |
604.15 | 31,302.28 | 88.01 | 4,286.70 | 15.12 | 337 | -98.18 | 53.01 | |
745.00 | 29,810.35 | 81.04 | 3,067.00 | 21.98 | 415 | -10.71 | 52.55 | |
6,352.25 | 17,240.18 | #1 31.73 | 599.90 | 11.69 | 58 | 24.89 | 59.01 | |
1,586.60 | 16,112.19 | 62.59 | 1,566.90 | 17.46 | 244 | 35.52 | 62.94 | |
678.05 | 9,453.06 | 255.15 | 2,218.14 | 12.97 | 28 | -55.88 | 70.93 |
Forecast
Actual
Growth Rate
Revenue Growth
28.68 %
Net Income Growth
1.73 %
Cash Flow Change
30.10 %
ROE
-8.82 %
ROCE
-11.54 %
EBITDA Margin (Avg.)
-6.75 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,824 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Fixed Assets | 740 | 1,478 | 2,244 | 2,227 | 2,192 | 2,380 | 6,536 | 7,018 | 7,039 | 8,784 | 11,502 |
| Current Assets | 383 | 289 | 349 | 454 | 447 | 768 | 1,125 | 1,000 | 1,943 | 1,706 | 1,593 |
| Capital Work in Progress | 18 | 12 | 46 | 38 | 87 | 6 | 27 | 151 | 252 | 553 | 901 |
| Investments | 143 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| Other Assets | 552 | 728 | 870 | 1,049 | 1,086 | 1,439 | 1,981 | 2,020 | 2,810 | 2,661 | 2,809 |
| Total Liabilities | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,824 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Current Liabilities | 282 | 419 | 381 | 477 | 1,140 | 1,474 | 777 | 757 | 1,046 | 1,249 | 1,814 |
| Non Current Liabilities | 339 | 672 | 1,660 | 1,806 | 1,262 | 1,363 | 2,129 | 2,149 | 1,647 | 2,343 | 4,020 |
| Total Equity | 832 | 1,127 | 1,119 | 1,031 | 963 | 987 | 5,639 | 6,283 | 7,410 | 8,408 | 9,381 |
| Reserve & Surplus | 343 | 587 | 655 | 627 | 426 | 450 | 4,673 | 5,313 | 6,439 | 7,436 | 8,409 |
| Share Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 16 | -40 | 4 | -6 | -2 | 267 | 516 | -318 | 893 | -395 | -319 |
| Investing Activities | -194 | -364 | -104 | -124 | -17 | -127 | 206 | -764 | -102 | -1,253 | -1,614 |
| Operating Activities | 64 | 53 | 156 | 166 | 89 | 250 | 118 | 741 | 1,284 | 1,122 | 1,459 |
| Financing Activities | 145 | 271 | -48 | -48 | -74 | 144 | 191 | -294 | -289 | -264 | -164 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 70.46 % | 70.46 % | 60.91 % | 60.68 % | 50.64 % | 50.64 % | 23.80 % | 23.78 % | 23.77 % | 23.76 % | 23.76 % | 23.75 % | 23.75 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.01 % | 57.33 % | 56.98 % | 57.29 % | 56.93 % | 54.74 % | 54.76 % |
| DIIs | 4.86 % | 7.93 % | 8.70 % | 15.60 % | 17.49 % | 19.26 % | 21.00 % | 20.47 % | 19.35 % | 11.90 % | 11.32 % | 11.34 % | 14.96 % | 15.36 % | 15.14 % | 15.55 % | 17.58 % | 17.42 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.18 % | 5.76 % | 5.20 % | 5.23 % | 5.41 % | 4.94 % | 4.54 % | 4.36 % | 3.72 % | 3.54 % | 3.55 % | 3.34 % | 3.29 % | 3.24 % | 3.18 % | 3.13 % | 3.31 % | 3.42 % |
| Others | 19.50 % | 15.84 % | 25.18 % | 18.49 % | 26.46 % | 25.16 % | 50.65 % | 51.38 % | 53.15 % | 60.80 % | 61.36 % | 61.56 % | 0.67 % | 0.67 % | 0.65 % | 0.64 % | 0.63 % | 0.66 % |
| No of Share Holders | 45,339 | 70,655 | 91,937 | 1,11,877 | 1,20,079 | 1,05,000 | 1,01,659 | 1,11,701 | 1,04,656 | 1,11,374 | 1,18,635 | 1,11,338 | 1,27,009 | 1,36,254 | 1,37,856 | 1,40,028 | 1,51,633 | 1,62,119 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.5 | 1.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.14 | 0.12 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2023 |  Dividend | ₹ 1.00 /share | 08 Sept 2023 | 519.90 | 602.65 |
| 27 Sept 2023 |  Annual General Meeting | NA | 27 Sept 2023 | 553.60 | 566.10 |
| 23 Aug 2024 | Dividend | ₹ 1.50 /share | 23 Aug 2024 | 835.15 | 869.30 |
| 20 Sept 2024 | Annual General Meeting | NA | 20 Sept 2024 | 882.75 | 984.55 |
| 05 Nov 2024 |  Quarterly Result Announcement | NA | 05 Nov 2024 | 994.50 | 1,036.60 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 1,082.95 | 1,025.90 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 1,159.90 | 1,187.10 |
| 04 Jul 2025 | Dividend | ₹ 1.50 /share | 04 Jul 2025 | 1,187.10 | 1,301.40 |
| 30 Jul 2025 | Annual General Meeting | NA | 30 Jul 2025 | 1,190.20 | 1,274.30 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 1,272.30 | 1,260.60 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
11 hours ago
11 hours agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication7 days ago
7 days agoAudio Recording Of Earnings Call Held On August 14 20257 days ago
7 days agoDisclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20157 days ago
7 days agoAgreement To Lease For Establishing A ~130 Bedded Built-To-Suit Hospital At Dehradun Uttarakhand8 days ago
8 days agoPresentation On Earnings Update8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
8 days agoBoard Meeting Outcome for Meeting Held On August 13 20258 days ago
8 days agoResults - Financial Results For Quarter Ended June 30 20258 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS9 days ago
9 days agoGrant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 20229 days ago
9 days agoMinutes Of 24Th Annual General MeetingAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Aug 06, 2025Board Meeting Intimation for Consideration And Approval Of Financial ResultsAug 06, 2025
Aug 06, 2025Transcript Of 24Th Annual General MeetingAug 05, 2025
Aug 05, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 30, 2025
Jul 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 30, 2025
Jul 30, 2025Summary Of Proceedings Of 24Th Annual General MeetingJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 15, 2025
Jul 15, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 11, 2025
Jul 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2025
Jul 05, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 04, 2025
Jul 04, 2025Reg. 34 (1) Annual Report.Jul 04, 2025
Jul 04, 2025Notice Of 24Th Annual General Meeting And Integrated Annual Report For The Financial Year 2024-25Jul 04, 2025
Jul 04, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 01, 2025
Jul 01, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 26, 2025
Jun 26, 2025Intimation Of Annual General Meeting Record Date And Communication To Members For Deduction Of Tax At Source On Final DividendJun 24, 2025
Jun 24, 2025Intimation Of Annual General Meeting Record Date And Communication To Members For Deduction Of Tax At Source
On Final DividendJun 24, 2025
Jun 24, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 27, 2025
May 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Audio Recording Of Earnings Call Held On May 21 2025May 21, 2025
May 21, 2025Appointment Of Secretarial Auditor And Cost AuditorMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sMay 20, 2025
May 20, 2025Presentation On Earnings UpdateMay 20, 2025
May 20, 2025Results For Quarter And Financial Year Ended March 31 2025May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
May 20, 2025Board Meeting Outcome for Meeting Held On May 20 2025May 20, 2025
May 20, 2025Execution Of Sale Deed For Acquisition Of Land And Building Situated In Uttar Pradesh By Crosslay Remedies LimitedMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 13, 2025
May 13, 2025Board Meeting Intimation for Financial Results And Recommendation Of Final DividendMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 11, 2025
May 11, 2025Rumour verification - Regulation 30(11)May 06, 2025
May 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Announcement under Regulation 30 (LODR)-Credit RatingApr 01, 2025
Apr 01, 2025Technical Indicators
RSI(14)
Neutral 51.14
ATR(14)
Less Volatile 33.38
STOCH(9,6)
Neutral 27.94
STOCH RSI(14)
Neutral 41.29
MACD(12,26)
Bearish -3.81
ADX(14)
Weak Trend 9.57
UO(9)
Bearish 44.75
ROC(12)
Downtrend And Accelerating -0.02
WillR(14)
Neutral -52.87
Mutual Fund Holdings
SBI Mid Cap Direct Plan-Growth 
Kotak Arbitrage Fund Direct-Growth 
Axis Midcap Direct Plan-Growth 
Invesco India Large & Mid Cap Fund Direct-Growth 
Quant Large Cap Fund Direct - Growth 
Tata India Pharma & Healthcare Fund Direct-Growth 
UTI Mid Cap Fund Direct-Growth 
WhiteOak Capital Mid Cap Fund Direct - Growth 
Mahindra Manulife Mid Cap Fund Direct - Growth 
Baroda BNP Paribas Health and Wellness Fund Direct-Growth 
Franklin India Large & Mid Cap Fund Direct-Growth 
Union Small Cap Fund Direct-Growth 
HDFC Pharma And Healthcare Fund Direct - Growth 
Bank of India Mid & Small Cap Equity & Debt Fund Direct-Growth 
JM Midcap Fund Direct - Growth About Max Healthcare Institute
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and Maharashtra. Max Healthcare has two strategic business units: Max Lab, which provides diagnostic services outside its hospital network, and Max@Home, offering health and wellness services at home. The company is listed on the BSE and NSE, with Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. as its current promoters.
Website
Chairperson NameAbhay Soi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
